PIERIANDX

In News

PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care - Business Wire

Business Wire - Oct 14, 2020

Medtech startup, spun out of WashU, acquired in deal that creates new company - The Business Journals

The Business Journals - Jan 13, 2023

TruSight Oncology 500: The Unifying Force has Arrived - Illumina

Illumina - Jan 08, 2019

Beyond the Bioinformatics Hype: How to Build Scalable, AI-Driven Tools That Deliver in Precision Medicine - GEN - Genetic Engineering and Biotechnology News

GEN - Genetic Engineering and Biotechnology News - Sep 05, 2025

Startup Velsera Launches to Advance Precision Health Through Data-Driven Solutions - HIT Consultant

HIT Consultant - Jan 13, 2023

Pamela Rose Hesker Obituary September 29, 2021 - Moll Funeral Home

Moll Funeral Home - Sep 29, 2021

PierianDx hires Sanderson as CEO - St. Louis - The Business Journals

The Business Journals - May 25, 2018

PierianDx und Pillar Biosciences kündigen Partnerschaft zur Unterstützung von präziser Krebsbehandlung an - Business Wire

Business Wire - Oct 14, 2020

Next-Generation Sequencing (NGS) Market to Reach US$ 31,411.3 Mn by 2026, Introduction of Rapid Sequencing Technologies Drives the Market: Fortune Business Insights - PR Newswire UK

PR Newswire UK - Aug 13, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment